Cargando…

DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study

Adoptive transfer of engineered NK cells, one of clinical approaches to fight cancer, is gaining great interest in the last decade. However, the development of new strategies is needed to improve clinical efficacy and safety of NK cell-based immunotherapy. NK cell-mediated recognition and lysis of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Focaccetti, Chiara, Benvenuto, Monica, Pighi, Chiara, Vitelli, Alessandra, Napolitano, Federico, Cotugno, Nicola, Fruci, Doriana, Palma, Paolo, Rossi, Paolo, Bei, Roberto, Cifaldi, Loredana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367496/ https://www.ncbi.nlm.nih.gov/pubmed/35967339 http://dx.doi.org/10.3389/fimmu.2022.886319

Ejemplares similares

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome
por: Brandetti, Elisa, et al.
Publicado: (2021)

The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors
por: Veneziani, Irene, et al.
Publicado: (2019)

DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
por: Cifaldi, Loredana, et al.
Publicado: (2019)

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
por: Melaiu, Ombretta, et al.
Publicado: (2020)

T and NK cells: two sides of tumor immunoevasion
por: Fruci, Doriana, et al.
Publicado: (2013)

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
por: Brandetti, Elisa, et al.
Publicado: (2017)

Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer
por: Cifaldi, Loredana, et al.
Publicado: (2012)

PlGF Immunological Impact during Pregnancy
por: Albonici, Loredana, et al.
Publicado: (2020)

IRF1 and NF-kB Restore MHC Class I-Restricted Tumor Antigen Processing and Presentation to Cytotoxic T Cells in Aggressive Neuroblastoma
por: Lorenzi, Silvia, et al.
Publicado: (2012)

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape
por: Caforio, Matteo, et al.
Publicado: (2021)

Epigenetic Deregulation of MicroRNAs in Rhabdomyosarcoma and Neuroblastoma and Translational Perspectives
por: Romania, Paolo, et al.
Publicado: (2012)

Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
por: Fontana, Laura, et al.
Publicado: (2008)

Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma
por: Palumbo, Camilla, et al.
Publicado: (2023)

Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors
por: Veneziani, Irene, et al.
Publicado: (2018)

Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
por: Melaiu, Ombretta, et al.
Publicado: (2020)

DNAM-1 controls NK cell activation via an ITT-like motif
por: Zhang, Zhanguang, et al.
Publicado: (2015)

Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells
por: Mantovani, Stefania, et al.
Publicado: (2022)

Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
por: Alisi, Anna, et al.
Publicado: (2013)

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy
por: D’Amico, Silvia, et al.
Publicado: (2022)

Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment
por: Paolini, Rossella, et al.
Publicado: (2023)

Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies
por: Benvenuto, Monica, et al.
Publicado: (2020)

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
por: Gamble, Laura D., et al.
Publicado: (2011)

An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with (177)Lu-DOTATATE for the treatment of neuroblastoma
por: Tesson, Mathias, et al.
Publicado: (2018)

Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1
por: Tong, Le, et al.
Publicado: (2023)

Quantification of the Immune Content in Neuroblastoma: Deep Learning and Topological Data Analysis in Digital Pathology
por: Bussola, Nicole, et al.
Publicado: (2021)

Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells
por: Veschi, Veronica, et al.
Publicado: (2012)

Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection
por: Lenac Rovis, Tihana, et al.
Publicado: (2016)

Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1
por: Walwyn-Brown, Katherine, et al.
Publicado: (2018)

Dynamic of Circulating DNAM-1+ Monocytes and NK Cells in Patients with STEMI Following Primary Percutaneous Coronary Intervention
por: Kumric, Marko, et al.
Publicado: (2022)

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer
por: Cifaldi, Loredana, et al.
Publicado: (2020)

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function
por: D’Amico, Silvia, et al.
Publicado: (2021)

NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses
por: Zingoni, Alessandra, et al.
Publicado: (2013)

Fighting Neuroblastomas with NBAT1
por: Pandey, Gaurav Kumar, et al.
Publicado: (2015)

NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
por: Fionda, Cinzia, et al.
Publicado: (2015)

Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor in Exosome-Mediated Cytotoxicity against Tumor
por: Di Pace, Anna Laura, et al.
Publicado: (2020)

Memory NK Cell Features Exploitable in Anticancer Immunotherapy
por: Capuano, Cristina, et al.
Publicado: (2019)

Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1
por: Kruse, Vanessa, et al.
Publicado: (2015)

Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells ⋆
por: Pucci, Carlotta, et al.
Publicado: (2022)

Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia
por: Valhondo, Isabel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_skno8vir3su6ti0cmkcql2gbai